|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/337 | |
| A61K 31/4188 | |||
| A61K 31/506 | |||
| A61K 45/06 | |||
| A61P 35/00 | |||
| A61P 43/00 |
| (11) | Patento numeris | 2670405 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12706925.0 |
| Europos patento paraiškos padavimo data | 2012-02-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-12-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-09-02 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2012/050513 |
| Data | 2012-02-03 |
| (87) | Numeris | WO 2012/104822 |
| Data | 2012-08-09 |
| (30) | Numeris | Data | Šalis |
| PCT/IB2011/0504 | 2011-02-04 | WO |
| (72) |
REGENASS, Urs, CH
|
| (73) |
Actelion Pharmaceuticals Ltd.,
Gewerbestrasse 16, 4123 Allschwil,
CH
|
| (54) | COMBINATIONS COMPRISING MACITENTAN FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME |
| COMBINATIONS COMPRISING MACITENTAN FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME |